Ipsita Volety is an expert in Infectiology at University of Illinois at Chicago (United States). Ipsita Volety has authored 14 publications, the most recent in 2026. SLR score: 21 (community average: 125). How the SLR is computed.

LeadR Profile

Ipsita Volety University of Illinois at Chicago United States
21 ScienceLeadR Reputation 21
Network Map

Infectiology

Subspecialties:

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2020 - 2026

Source: PubMed

University of Illinois at Chicago

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 14

Citations

Citations: 199 1st author: 0 Last author: 0 Unique author: 0


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Loss of Akt3 enhances antiviral immunity while disrupting corneal homeostasis during ocular HSV-1 infection.
PMID 42656328 — genes, eye infections, protein isoforms, homeostasis, neutrophils, herpesvirus 1, human, immune system diseases, immunity, antiviral agents, infections
Front Immunol20260
MLKL‒OPTN axis regulates herpesvirus-induced neurological sequelae.
PMID 40490945 — oligodendroglia, necroptosis, herpesvirus 1, human, viruses, demyelinating diseases, cell death, infections
Clin Transl Med20250
Heparanase 2 Modulation Inhibits HSV-2 Replication by Regulating Heparan Sulfate.
PMID 39772142 — cells, heparitin sulfate, virology, herpesvirus 2, human, virus replication, transfection, infections, heparanase
Viruses20241
OPTN-TBK1 axis and a role for PLK1 in HSV-1 infection.
PMID 38019030 — eye infections, microbiological phenomena, herpesvirus 1, human, latent infection
mBio20234
Unique Attributes of Guinea Pigs as New Models to Study Ocular Herpes Pathophysiology and Recurrence.
PMID 38015175 — infections, pathology, ophthalmology, conjunctivitis, herpesvirus 1, human, weight loss, blepharitis, therapeutics, trifluridine, keratitis, acyclovir
Invest Ophthalmol Vis Sci20239

LeadR Networks

Main global connection map